Literature DB >> 22173015

Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it.

C J Riebe1, F A Pamplona, F Pamplona, K Kamprath, C T Wotjak.   

Abstract

The endocannabinoid system seems to play very specific roles in fear extinction, which can only be described within a well-defined model of the various fear relief processes. We, therefore, seek to clarify the current conceptual framework of fear relief within classical and operant fear conditioning paradigms as well as propose new clarifications within this framework where necessary. Based on these revisions as well as previous research involving the endocannabinoid system and fear relief, we are able to pinpoint the processes in which endocannabinoids seem to play a significant role. Following auditory-cued fear conditioning, this applies in particular to habituation and its involvement in acute and long-lasting fear relief. Following contextual conditioning, in contrast, endocannabinoids seem to affect relearning processes as well. Furthermore, we describe how the involvement of the endocannabinoid system develops over the course of the fear relief process and what this may imply for the clinical use of pharmacotherapies targeting the endocannabinoid system in treating fear and anxiety disorders. Copyright Â
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173015     DOI: 10.1016/j.neuroscience.2011.11.057

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

1.  Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

Authors:  O Gunduz-Cinar; K P MacPherson; R Cinar; J Gamble-George; K Sugden; B Williams; G Godlewski; T S Ramikie; A X Gorka; S O Alapafuja; S P Nikas; A Makriyannis; R Poulton; S Patel; A R Hariri; A Caspi; T E Moffitt; G Kunos; A Holmes
Journal:  Mol Psychiatry       Date:  2012-06-12       Impact factor: 15.992

Review 2.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

3.  2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.

Authors:  Alvaro Llorente-Berzal; Ana Luisa B Terzian; Vincenzo di Marzo; Vincenzo Micale; Maria Paz Viveros; Carsten T Wotjak
Journal:  Psychopharmacology (Berl)       Date:  2015-03-28       Impact factor: 4.530

Review 4.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 5.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

6.  Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Authors:  Joyonna C Gamble-George; Jordan R Conger; Nolan D Hartley; Prerna Gupta; Joshua J Sumislawski; Sachin Patel
Journal:  Psychopharmacology (Berl)       Date:  2013-03-13       Impact factor: 4.530

7.  Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.

Authors:  Mateus M Bergamaschi; Regina H C Queiroz; Marcos H N Chagas; Ila M P Linares; Kátia C Arrais; Danielle C G de Oliveira; Maria E Queiroz; Antonio E Nardi; Marilyn A Huestis; Jaime E C Hallak; Antonio W Zuardi; Fabrício A Moreira; José A S Crippa
Journal:  Hum Psychopharmacol       Date:  2013-12-03       Impact factor: 1.672

8.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

Review 9.  Developmental regulation of fear learning and anxiety behavior by endocannabinoids.

Authors:  T T-Y Lee; M N Hill; F S Lee
Journal:  Genes Brain Behav       Date:  2015-11-05       Impact factor: 3.449

Review 10.  Individual differences in recovery from traumatic fear.

Authors:  Andrew Holmes; Nicolas Singewald
Journal:  Trends Neurosci       Date:  2012-12-19       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.